Form 4: Neurocrine Biosciences Executive Exercises Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Ingrid Delaet, Chief Regulatory Officer of Neurocrine Biosciences, exercised stock options and sold shares according to a pre-arranged trading plan.
Summary
- On August 6, 2024, Ingrid Delaet, Chief Regulatory Officer of Neurocrine Biosciences, exercised non-qualified stock options to acquire 273 shares of common stock at a price of $79.02 per share.
- On the same day, Ms. Delaet sold 273 shares of Neurocrine Biosciences common stock at $147.7 per share.
- The transactions were executed under a Rule 10b5-1 trading plan adopted on November 29, 2023.
- Following these transactions, Ms. Delaet directly owns 6,607 shares of common stock and 4,081 derivative securities (stock options).
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects routine insider trading activity under a pre-arranged plan. There is no indication of positive or negative implications for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It indicates that a company executive is exercising stock options and selling shares, which is a common practice. The use of a 10b5-1 trading plan suggests the executive is selling shares in a pre-planned manner to avoid accusations of trading on inside information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by an executive, but the pre-planned nature of the sale mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| November 29, 2023 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| January 31, 2022 | Date the non-qualified stock options were granted |
| February 28, 2022 | Start date of the 48 equal monthly installments for vesting of the options |
| August 06, 2024 | Date of the transaction (exercise of options and sale of shares) |
| August 08, 2024 | Date of signature for the Form 4 filing |
| January 31, 2032 | Expiration date of the non-qualified stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.